KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Other Non Operating Income: 2011-2024

Historic Other Non Operating Income for Sarepta Therapeutics (SRPT) over the last 13 years, with Dec 2024 value amounting to $42.7 million.

  • Sarepta Therapeutics' Other Non Operating Income fell 682.24% to -$83.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$47.0 million, marking a year-over-year decrease of 284.80%. This contributed to the annual value of $42.7 million for FY2024, which is 111.02% up from last year.
  • According to the latest figures from FY2024, Sarepta Therapeutics' Other Non Operating Income is $42.7 million, which was up 111.02% from -$387.3 million recorded in FY2023.
  • In the past 5 years, Sarepta Therapeutics' Other Non Operating Income registered a high of $42.7 million during FY2024, and its lowest value of -$387.3 million during FY2023.
  • Moreover, its 3-year median value for Other Non Operating Income was -$125.4 million (2022), whereas its average is -$156.7 million.
  • In the last 5 years, Sarepta Therapeutics' Other Non Operating Income plummeted by 208.77% in 2023 and then spiked by 111.02% in 2024.
  • Sarepta Therapeutics' Other Non Operating Income (Yearly) stood at -$61.2 million in 2021, then plummeted by 104.84% to -$125.4 million in 2022, then plummeted by 208.77% to -$387.3 million in 2023, then soared by 111.02% to $42.7 million in 2024.